[PDF][PDF] Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a …
…, H Miwa, SK Qin, IJ Chung, KH Yeh, JF Feng… - J Clin Oncol, 2014 - academia.edu
Purpose In Asian countries, paclitaxel once per week is used as second-line treatment in
advanced gastric cancer, including human epidermal growth factor receptor 2 (HER2)–positive …
advanced gastric cancer, including human epidermal growth factor receptor 2 (HER2)–positive …
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label …
…, ZF Jiang, XJ Wang, GY Lou, DG Liu, JF Feng… - The lancet …, 2015 - thelancet.com
Background Platinum chemotherapy has a role in the treatment of metastatic triple-negative
breast cancer but its full potential has probably not yet been reached. We assessed whether …
breast cancer but its full potential has probably not yet been reached. We assessed whether …
[HTML][HTML] Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell …
JF Feng, Y Huang, QX Chen - World journal of surgical oncology, 2014 - Springer
Background Recent studies have shown that the presence of systemic inflammation
correlates with poor survival in various cancers. The aim of this study was to determinate the …
correlates with poor survival in various cancers. The aim of this study was to determinate the …
[HTML][HTML] Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus
JF Feng, S Chen, X Yang - Medicine, 2017 - journals.lww.com
… Correspondence: Ji-Feng Feng, Department of Thoracic Surgery, Zhejiang Cancer
Hospital, Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology …
Hospital, Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology …
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2–advanced breast cancer: the multinational randomized phase III study
…, N Liao, XH Wu, XJ Wang, JF Feng… - … in medical oncology, 2020 - journals.sagepub.com
Aim: To compare the efficacy, safety, and tolerability of abemaciclib plus endocrine therapy (ET)
versus ET alone in postmenopausal women with hormone receptor (HR)-positive, …
versus ET alone in postmenopausal women with hormone receptor (HR)-positive, …
Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma
JF Feng, QX Chen - Therapeutics and clinical risk management, 2013 - Taylor & Francis
Background The prognostic nutritional index (PNI) is related to the prognosis in many cancers;
however, its role in esophageal cancer is still controversial. Further, controversy exists …
however, its role in esophageal cancer is still controversial. Further, controversy exists …
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
WP Xu, JP Liu, JF Feng, CP Zhu, Y Yang, WP Zhou… - Gut, 2020 - gut.bmj.com
Objective Autophagy participates in the progression of hepatocellular carcinoma (HCC) and
the resistance of HCC cells to sorafenib. We investigated the feasibility of sensitising HCC …
the resistance of HCC cells to sorafenib. We investigated the feasibility of sensitising HCC …
MiR-138: A promising therapeutic target for cancer
…, SW Liu, Z Wang, DL Yan, SC Dong, JF Feng - Tumor …, 2017 - journals.sagepub.com
MicroRNAs are small noncoding RNAs which regulate gene expressions at post-transcriptional
level by binding to the 3′-untranslated region of target messenger RNAs. Growing …
level by binding to the 3′-untranslated region of target messenger RNAs. Growing …
[HTML][HTML] Clinical significance of preoperative neutrophil lymphocyte ratio versus platelet lymphocyte ratio in patients with small cell carcinoma of the esophagus
JF Feng, Y Huang, Q Zhao, QX Chen - The Scientific World Journal, 2013 - hindawi.com
Recent studies have shown that the presence of systemic inflammation correlates with poor
survival in various of cancers. The aim of this study was to determine the prognostic values …
survival in various of cancers. The aim of this study was to determine the prognostic values …
Combination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell …
JF Feng, Y Huang, JS Liu - OncoTargets and therapy, 2013 - Taylor & Francis
Background Recent studies have shown that the presence of systemic inflammation correlates
with poor survival in various types of cancers. This study investigated the usefulness of a …
with poor survival in various types of cancers. This study investigated the usefulness of a …